Anemia in adults with congenital heart disease relates to adverse outcome. J Am Coll Cardiol. 2009;54:2093 100. S2.3-16. Dimopoulos K, Diller G-P, Petraco R, et al. Hyponatraemia: a strong predictor of mortality in adults with congenital heart disease. Eur Heart J. 2010;31:595 601. S2.3-17. Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;128:e240 327. 3. GENERAL PRINCIPLES 3.1. ACHD Program S3.1-1. Mylotte D, Pilote L, Ionescu-Ittu R, et al. Specialized adult congenital heart disease care: the impact of policy on mortality. Circulation. 2014;129:1804 12. 3.2. Access to Care S3.2-1. Gurvitz M, Valente AM, Broberg C, et al. Prevalence and predic- tors of gaps in care among adult congenital heart disease patients: HEART-ACHD (The Health, Education, and Access Research Trial). J Am Coll Cardiol. 2013;61:2180 4. S3.2-2. Mackie AS, Islam S, Magill-Evans J, et al. Healthcare transition for youth with heart disease: a clinical trial. Heart. 2014;100:1113 8. S3.2-3. Yeung E, Kay J, Roosevelt GE, et al. Lapse of care as a predictor for morbidity in adults with congenital heart disease. Int J Cardiol. 2008;125:62 5. S3.2-4. Wacker A, Kaemmerer H, Hollweck R, et al. Outcome of operated and unoperated adults with congenital cardiac disease lost to fol- low-up for more than five years. Am J Cardiol. 2005;95:776 9. S3.2-5. Mylotte D, Pilote L, Ionescu-Ittu R, et al. Specialized adult congenital heart disease care: the impact of policy on mortality. Circulation. 2014;129:1804 12. 3.3. Delivery of Care S3.3-1. Mylotte D, Pilote L, Ionescu-Ittu R, et al. Specialized adult congenital heart disease care: the impact of policy on mortality. Circulation. 2014;129:1804 12. S3.3-2. Karamlou T, Diggs BS, Person T, et al. 